PropertyValue
?:abstract
  • Cancer is considered a group of diseases characterized by uncontrolled growth and spread of abnormal cells and is propelled by somatic mutations. Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3) family of enzymes are endogenous sources of somatic mutations found in multiple human cancers. While these enzymes normally act as an intrinsic immune defence against viruses, they can also catalyse ‘off-target’ cytidine deamination in genomic single-stranded DNA intermediates. The deamination of cytosine forms uracil, which is promutagenic in DNA. Key factors to trigger the APOBEC ‘off-target’ activity are overexpression in a non-normal cell type, nuclear localization and replication stress. The resulting uracil-induced mutations contribute to genomic variation, which may result in neutral, beneficial or harmful consequences for the cancer. This review summarizes the functional and biochemical basis of the APOBEC3 enzyme activity and highlights their relationship with the most well-studied cancers in this particular context such as breast, lung, bladder, and human papillomavirus-associated cancers. We focus on APOBEC3A, APOBEC3B and APOBEC3H haplotype I because they are the leading candidates as sources of somatic mutations in these and other cancers. Also, we discuss the prognostic value of the APOBEC3 expression in drug resistance and response to therapies.
is ?:annotates of
?:creator
?:doi
  • 10.1098/rsob.200188
?:doi
?:journal
  • Open_Biol
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/5d90b972bceb7ccae6bf994da6093a7832cf5f85.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7776566.xml.json
?:pmcid
?:pmid
?:pmid
  • 33292100.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • The interesting relationship between APOBEC3 deoxycytidine deaminases and cancer: a long road ahead
?:type
?:year
  • 2020-12-09

Metadata

Anon_0  
expand all